Effect of curcumin in treatment of respiratory syndrome of corona

Phase 2

Recruiting

• Conditions: U07.1; Covid-19 disease; Covid-19.

• Registration Number: IRCT20200418047119N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

All people with acute respiratory syndrome of corona

Exclusion Criteria

Patients with high risk or patients with acute respiratory conditions who enter the ICU from the beginning

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body temperature. Timepoint: Body temperature is measured at the beginning of the study, on the third and seventh days. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: The percentage of oxygen saturation is measured at the beginning of the study, on the third and seventh days. Method of measurement: Oxymeter.;Lung inflammation observed with CT scan. Timepoint: The CT scan image is taken at the beginning of the study and on the third and seventh days. Method of measurement: CT-scan imaging.